The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
94% reported they consume cannabis for at least one medical or health reason.
A new report urges housing providers to support tenants who may be prescribed cannabis-based medicines.
The partnership aims to improve treatment options available to patients with chronic pain.
Experts are urging clinics to follow best practice guidelines as the industry reaches a 'tipping point'.
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the...
The Cognalyzer® scans EEG (brainwaves) of consumers and leverages AI to quantify if a person is experiencing psychoactive effects.
MRX1 demonstrated “cardioprotective effects” in a pre-clinical study.
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company....
Script Assist's medical cannabis technology platform will now be available on a software as a service (SaaS) basis for the first time.
